期刊文献+

类风湿关节炎患者IL-18检测的影响因素分析 被引量:1

Analysis on influencing factors of IL-18 detection in rheumatoid arthritis
下载PDF
导出
摘要 目的探讨不同的保存时间、温度对类风湿关节炎(RA)患者外周血与关节积液IL-18水平的影响。方法将12例RA患者的血清与关节积液按照不同保存时间与温度条件分为A组(血清,室温0h)、B组(全血,室温36h)、C组(全血,室温72h)、D组(全血,4℃72h)、E组(血清,室温72h)、F组(关节液,室温0h)、G组(关节液,室温72h),用ELISA检测各组IL-18浓度变化。结果 B、D、E组IL-18浓度明显高于A组(均P<0.05);F组IL-18浓度与A组比较差异无统计学意义(P>0.05)。非参数两关联样本检验显示C组IL-18浓度明显高于A、B、D组;G组IL-18浓度明显高于F组(P<0.05)。结论外周血及关节积液IL-18水平变化趋势一致,IL-18检测受时间和温度影响,且温度影响更显著。 Objective To study the influence of different preservation time and temperature on the IL-18 level of peripheral blood and joint effusion in the patients with rheumatoid arthritis(RA). Methods Serum and joint effu- sion in 12 cases of RA were divided into the group A(serum at room temperature for 0 h),g(whole blood at room temperature for 36 h),C(whole blood at room temperature for 72 h),D(whole blood at 4 ℃ for 72 h),E(serum at room temperature for 72 h), F(joint fluid at room temperature for 0 h) ,G(joint fluid at room temperature for 72 h) according to the different storage time and temperature conditions. The changes of IL-18 concentration in various groups were detected by ELISA. Results The IL-18 concentration in the group B,D and E was significantly higher than that in the group A(all P〈0.05). The IL-18 concentration had no statistical difference between the group A and F(P〉0.05). Non-parametric two-related sample test showed that the IL-18 concentration in the group C was signifi- cantly higher than that in the group A,B and D;which in the group G was significantly higher than the group F(P〈0.05). Conclusion The change of IL-18 level in peripheral blood and joint effusion demonstrates the consistent trend,the IL-18 detection is affected by the time and temperature, especially temperature influence is more signifi- cant.
出处 《检验医学与临床》 CAS 2013年第6期652-653,共2页 Laboratory Medicine and Clinic
关键词 类风湿关节炎 白细胞介素-18 保存时间 温度 rheumatoid arthritis IL-18 preservation time temperature
  • 相关文献

参考文献10

  • 1Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis [J]. Lancet,2010,376(9746) : 1094-1108.
  • 2Klareskog L, Catrina AI, Paget S, et al. Rheumatoid ar- thritis[J]. Lancet, 2009,373 (9664) : 659-672.
  • 3Shao XT, Feng L, Gu LJ, et al. Expression of interleukin- 18, IL-18BP, and IL-18R in serum, synovial fluid, and syn- ovial tissue in patients with rheumatoid arthritis[J]. Clin Exp Med,2009,9(3) :215-221.
  • 4曲瑾.类风湿关节炎关节滑膜细胞中IL-18表达及意义[J].山东医药,2008,48(48):99-100. 被引量:3
  • 5Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/Europe-an League Against Rheumatism collaborative [J]. Arthritis Rheum, 2010, 62 (9): 2569- 2581.
  • 6Brennan FM, Mclnnes IB. Evidence that cytokines play a role in rheumatoid arthritis [J]. J Clin Invest, 2008, 118 (11) :3537-3545.
  • 7Bokarewa M, Hultgren O. Is interleukim18 useful for mo- nitoring rheumatoid arthritis [J]. Scand J Rheumatol, 2005,34(6) :433-436.
  • 8王叶萍,姚航平.类风湿性关节炎患者血清和滑液IL-18及IL-18结合蛋白的水平及意义[J].检验医学,2004,19(6):518-520. 被引量:9
  • 9Bresnihan B, Roux Lombard P, Murphy E, et al. Serum in- terleukin 18 and interleukin 18 binding protein in rheuma- toid arthrtis[J]. Ann Rheum Dis, 2002,61 (8) : 726-729.
  • 10Brown AK,Conaghan PG, Karim Z, et al. An explanation for the apparent Dissoeition between clinical remission and continued structrual deterioration in rheumatoid ar- thritis[J]. Arthritis Rheum, 2008,58 (10) : 2958-2967.

二级参考文献12

  • 1Pay S, Erdem H, Pekel A, et al. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behcetg disease. Does interleukin-lbeta play a major role in Behcet's synovitis? [J]. Rheumatol,2006,26(7) :608-613.
  • 2Petrovic-Rackov L, Pejnovic N. Clinical significance of IL-18, IL- 15, IL-12 and TNF-alpha measurement in rheumatoid arthritis [ J]. Clin Rheumatol, 2006,25(4) :448-52.
  • 3Kohno K,Kataoka J,Ohtsuki T,et al.IFN-gamma-inducing factor(IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12[J].J Immunol,1997,158:1541-1550.
  • 4Gu Y,Kaida K,Tsutsui H,et al.Activation of interferon-gamma-inducing factor mediated by interleukin-1 beta converting enzyme[J].Science,1997,275:206-209.
  • 5Gracie JA,Forsey RJ,Chan WL,et al.A proinflammatory role for IL-18 in rheumatoid arthritis[J].J Clin Invest,1999,104:1337-1339.
  • 6Konishi K,Tanabe F,Taniguchi M,et al.A simple and sensitive bioassay for the detection of human interleukin-18/interferon-r-inducing factor using human myelomonocytic KG-1 cells[J].J Immunol Methods,1997,209:189-191.
  • 7Yudoh K,Matsuno H,Nakazawa F,et al.Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis[J].Arthritis Rheum,2000,43:617-627.
  • 8Olee T,Hashimoto S,Quach J,et al.IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses[J].J Immunol,1999,162:1096-1100.
  • 9Wei XQ,Leung BP,Arthur HM,et al.Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18[J].J Immunol,2001,166:517-521.
  • 10Munakata T,Uzuki M,Shimamura T,et al.Dynamics of interleukin-18 in serum,synovial fluid and synovial membrane in the patients with rheumatoid arthritis[J].Ryumachi,2001,41:625-634.

共引文献9

同被引文献15

  • 1Liew FY, Mcinnes IB. Role of interleukin 15 and interleukin 18 ininflammatory response[J]. Ann Rheum Dis,2002, 61 ( 2 ) : 100-102.
  • 2Bush KA, Walker JS,Lee CS, et al. Cytokine expression and syno-vial pathology in the initiation and spontaneous resolution phasesof adjuvant arthritis: interleukin-17 expression is upregulated inearly disease[J]. Clin Exp Immunol,2001,123(3) :487-495.
  • 3Bush KA?Farmer KM, Walker JS,et al. Reduction of joint inflam-mation and bone erosion in rat adjuvant arthritis by treatmentwith interleukin-17 receptor IgGl Fc fusion protein[J], ArthritisRheum,2002,46(3) :802-805.
  • 4Dudler J, Renggli-Zulliger N, Busso N, et al. Effect of interleukin17 on proteoglycan degradation in murine knee joints[J], AnnRheum Dis,2000,59(7) :529-532.
  • 5Numasaki M, Fukushi J,Ono M, et al. Interleukin-17 promotesangiogenesis and tumor growth[J]. Blood, 2003 ,101 (7): 2620-2627.
  • 6Dinarello CA. Interleukin-18 and the pathogenesis of inflammato-ry diseases[J]. Semin Nephrol,2007 ,27(1) : 98-114.
  • 7曾颖瑜,陶怡.类风湿关节炎早期诊断的血清学检查研究进展[J].广东医学,2008,29(3):518-520. 被引量:5
  • 8梁柳琴,詹钟平,邱茜,叶玉津,许韩师,杨岫岩.类风湿关节炎治疗前后血清基质金属蛋白酶-3的变化[J].实用医学杂志,2008,24(11):1901-1903. 被引量:4
  • 9陈颖,陈曲波.Th17细胞在炎性疾病中的作用[J].国际检验医学杂志,2009,30(12):1176-1177. 被引量:6
  • 10陈良东,林洁,周剑波,顾丽萍.类风湿关节炎患者IL-17、IL-18、IL-6和TNF-α检测的意义[J].当代医学,2010,16(7):13-14. 被引量:42

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部